News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Advanced Plant Pharmaceuticals, Inc. (APPI) And Subsidiary, Mazal Plant Pharmaceuticals Inc., File Investigational New Drug Application With FDA For Cholesterol-Lowering Drug



10/19/2005 5:12:50 PM

NEW YORK, April 14, 2005 (PRIMEZONE) -- Advanced Plant Pharmaceuticals, Inc. (OTCBB:APPI) and its majority owned subsidiary, Mazal Plant Pharmaceuticals Inc., announced today that Mazal has filed an Investigational New Drug Application (IND) with the United States Food and Drug Administration (FDA) for approval to begin Phase I/II clinical trials of MAHDL01, a pharmaceutical for modifying cholesterol in hypercholesterolemic patients.

Read at Prime Zone


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES